INFIMEDIC
Sources: the KBO register on 18-11-2026; the National Bank, 2025 annual accounts filed on 14-07-2026; the Belgian Official Gazette, latest deed of 08-09-2022.
Grounds
the facts the verdict rests on, each with its source- In 2025, INFIMEDIC closed with a net profit of €6,024.Annual accounts 2025 page 2
- Equity stands at €73,343, or 95.0% of the balance sheet total of €77,223.Annual accounts 2025 page 2
- The 2025 accounts reached the National Bank 17 days before the end of the term.National Bank, filing of 14-07-2026 page 4
Representation
Checked did not find the signing rule in the deeds it read.
Ownership
Accounts in the micro format list no shareholders. Checked found none in the deeds or the LEI register either.
Financial situation
Annual accounts 2021 to 2025, as filed with the National Bank
Gross margin and net resultin euro
Equity and debtsin euro
Cashin euro
| Financial year | 2021 | 2022 | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|---|
| Results | ||||||
| Gross margin | €170,006 | €128,609 | €108,598 | €119,883 | €123,849 | |
| Operating result | €28,443 | €5,570 | -€21,851 | €20,008 | €6,571 | |
| Net result | €28,369 | €4,690 | -€22,756 | €19,305 | €6,024 | |
| Balance sheet at the closing date | ||||||
| Equity | €66,080 | €70,770 | €48,014 | €67,319 | €73,343 | |
| Debts | €5,247 | €5,779 | €3,105 | €2,935 | €3,880 | |
| Debts due within one year | €5,247 | €5,779 | €3,105 | €2,935 | €3,880 | |
| Cash | €39,170 | €46,103 | €28,918 | €53,154 | €60,295 | |
| Balance sheet total | €71,327 | €76,549 | €51,119 | €70,254 | €77,223 | |
| Operations | ||||||
| Employees in full-time equivalents | 3.6 | 3.2 | 3.4 | 3.2 | 2.7 | |
| Ratios | ||||||
| Solvency | 92.6% | 92.5% | 93.9% | 95.8% | 95.0% | |
| Liquidity | 8.51 | 9.04 | 9.67 | 20.34 | 15.77 | |
Source: Annual accounts 2025, micro format, filed on 14-07-2026 (2026-00291119); Annual accounts 2024, micro format, filed on 18-07-2025 (2025-00288124); Annual accounts 2021 to 2023, filed from 29-08-2022 to 29-08-2024 (2022-20411033, 2023-00404975, 2024-00398719).
The operating result of 2025 is 67% lower than in 2024.
Debts rose by €945 in 2025, of which €2,350 to suppliers.
The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.
INFIMEDIC states no turnover; the micro format does not require it. The gross margin, what is left after purchases, rose from €119,883 to €123,849.
Board, signature and ownership
Position on 18-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
Checked did not find the signing rule in the deeds it read.
Board
three directors in officeOwnership and group
Shareholders
Accounts in the micro format list no shareholders. Checked found none in the deeds or the LEI register either.
Board changes
Registered office moved from Brussels to Laken. The registered office moved from 55 rue gustave demanet à 1020 Bruxelles to drêve Sainte Anne 68 B à 1020 Laken. resigns as director. appointed as director. General meeting of 02-12-2014.
Gazette, deed 15004840resigns. and reappointed. appointed. General meeting of 24-03-2014.
Gazette, deed 14075273resigns. , and reappointed. General meeting of 03-01-2013.
Gazette, deed 13017723Events and comparison
The last 24 months, newest first
Annual accounts 2025 filed, 17 days before the deadline.
NBB filingAnnual accounts 2024 filed, 13 days before the deadline.
NBB filingBack to profit. The net result is €19,305, after one loss-making year.
FinancialLiquidity more than doubled. The current ratio rises from 9.67 to 20.34. Short-term debt falls from €3,105 to €2,935.
FinancialComparable companies, two years later
In July 2024, 31,389 companies had the same profile as INFIMEDIC has now: micro, 20 years or older, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 93.4% were still trading, 6.1% had stopped another way and 0.5% had gone bankrupt.
In 2025, INFIMEDIC had a lower net result than 86% of the 21,324 companies in the human health sector (NACE 86).
Other findings
Peppol
Not listed in the Peppol Directory.
Sanctions lists
Staff
3 employees on 31-12-2025, 1.2 full-time equivalents on average over the year.
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 18-11-2026 | KBO 0474.901.211 |
| National Bank of Belgium | Annual accounts 2025, micro format | 14-07-2026 | 2026-00291119 |
| National Bank of Belgium | Annual accounts 2024, micro format | 18-07-2025 | 2025-00288124 |
| National Bank of Belgium | Annual accounts 2021 to 2023 | 29-08-2022 to 29-08-2024 | 2022-20411033, 2023-00404975, 2024-00398719 |
| Belgian Official Gazette | Board | 09-01-2015 | deed 15004840 |
| Belgian Official Gazette | Board | 07-04-2014 | deed 14075273 |
| Belgian Official Gazette | Board | 30-01-2013 | deed 13017723 |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 16-11-2026 | no match |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 17-11-2026 | bankruptcy model of 2 October 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 17-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.